Patrick Fabbio - 19 Jan 2024 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role
Chief Financial Officer
Signature
/s/ Patrick Fabbio
Issuer symbol
TARA
Transactions as of
19 Jan 2024
Net transactions value
$0
Form type
4
Filing time
23 Jan 2024, 16:05:22 UTC
Previous filing
30 Jan 2023
Next filing
31 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARA Common Stock Award $0 +22,000 $0.000000 22,000 19 Jan 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TARA Stock Option (Right to Buy) Award $0 +131,000 $0.000000 131,000 19 Jan 2024 Common Stock 131,000 $1.91 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 19, 2024.
F2 25% of the shares vest on the one year anniversary of January 19, 2024 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.